Avid Bioservices, Inc. (CDMO)
NASDAQ: CDMO · IEX Real-Time Price · USD
9.53
+1.21 (14.54%)
At close: Jul 16, 2024, 4:00 PM
9.55
+0.02 (0.21%)
After-hours: Jul 16, 2024, 4:15 PM EDT

Avid Bioservices Revenue

In the fiscal year ending April 30, 2024, Avid Bioservices had annual revenue of $139.91M. Revenue in the quarter ending April 30, 2024 was $42.98M with 7.98% year-over-year growth.

Revenue (ttm)
$139.91M
Revenue Growth
-6.27%
P/S Ratio
4.33
Revenue / Employee
$377,119
Employees
371
Market Cap
605.93M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Apr 30, 2024139.91M-9.36M-6.27%
Apr 30, 2023149.27M29.67M24.81%
Apr 30, 2022119.60M23.73M24.75%
Apr 30, 202195.87M36.17M60.58%
Apr 30, 202059.70M6.10M11.38%
Apr 30, 201953.60M-18.00K-0.03%
Apr 30, 201853.62M-4.01M-6.96%
Apr 30, 201757.63M13.27M29.92%
Apr 30, 201644.36M17.58M65.63%
Apr 30, 201526.78M4.38M19.55%
Apr 30, 201422.40M718.00K3.31%
Apr 30, 201321.68M6.45M42.34%
Apr 30, 201215.23M1.74M12.90%
Apr 30, 201113.49M-14.45M-51.72%
Apr 30, 201027.94M9.79M53.95%
Apr 30, 200918.15M12.06M197.90%
Apr 30, 20086.09M2.39M64.32%
Apr 30, 20073.71M515.00K16.13%
Apr 30, 20063.19M-1.77M-35.61%
Apr 30, 20054.96M1.65M49.64%
Apr 30, 20043.31M-607.00K-15.48%
Apr 30, 20033.92M155.00K4.12%
Apr 30, 20023.77M2.79M284.68%
Apr 30, 2001979.00K929.00K1,858.00%
Apr 30, 200050.00K--
Apr 30, 19990--
Apr 30, 19980--
Apr 30, 19970--
Apr 30, 19963.14M3.14M42,429.06%
Apr 30, 19957.39K-61.98K-89.34%
Apr 30, 199469.37K--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Community Health Systems 12.52B
Castle Biosciences 250.73M
Canopy Growth 218.49M
Contineum Therapeutics 50.00M
OmniAb 21.05M
Fate Therapeutics 6.48M
PureTech Health 3.33M
Revenue Rankings